Your browser doesn't support javascript.
loading
Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice.
Nanna, Michael G; Kolkailah, Ahmed A; Page, Courtney; Peterson, Eric D; Navar, Ann Marie.
Affiliation
  • Nanna MG; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Kolkailah AA; Division of Cardiology, UT Southwestern Medical Center, Dallas, Texas.
  • Page C; Duke Clinical Research Institute, Durham, North Carolina.
  • Peterson ED; Division of Cardiology, UT Southwestern Medical Center, Dallas, Texas.
  • Navar AM; Division of Cardiology, UT Southwestern Medical Center, Dallas, Texas.
JAMA Cardiol ; 8(1): 89-95, 2023 01 01.
Article in En | MEDLINE | ID: mdl-36322056
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans Language: En Journal: JAMA Cardiol Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans Language: En Journal: JAMA Cardiol Year: 2023 Document type: Article